Carnegie Investment Counsel Buys 8,474 Shares of UnitedHealth Group Incorporated $UNH

Carnegie Investment Counsel boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8.9% during the second quarter, Holdings Channel.com reports. The firm owned 103,305 shares of the healthcare conglomerate’s stock after purchasing an additional 8,474 shares during the quarter. Carnegie Investment Counsel’s holdings in UnitedHealth Group were worth $32,228,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in the stock. Nabity Jensen Investment Management Inc boosted its position in UnitedHealth Group by 0.9% during the first quarter. Nabity Jensen Investment Management Inc now owns 2,760 shares of the healthcare conglomerate’s stock valued at $1,446,000 after purchasing an additional 24 shares in the last quarter. Atlantic Edge Private Wealth Management LLC boosted its holdings in UnitedHealth Group by 8.9% in the first quarter. Atlantic Edge Private Wealth Management LLC now owns 305 shares of the healthcare conglomerate’s stock worth $160,000 after acquiring an additional 25 shares in the last quarter. HHM Wealth Advisors LLC boosted its holdings in UnitedHealth Group by 0.9% in the first quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate’s stock worth $1,544,000 after acquiring an additional 26 shares in the last quarter. Brogan Financial Inc. boosted its holdings in UnitedHealth Group by 3.4% in the first quarter. Brogan Financial Inc. now owns 819 shares of the healthcare conglomerate’s stock worth $429,000 after acquiring an additional 27 shares in the last quarter. Finally, West Wealth Group LLC boosted its holdings in UnitedHealth Group by 3.2% in the first quarter. West Wealth Group LLC now owns 882 shares of the healthcare conglomerate’s stock worth $462,000 after acquiring an additional 27 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 0.3%

Shares of UNH stock opened at $360.48 on Friday. The stock has a 50 day moving average of $337.26 and a 200 day moving average of $340.29. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a market cap of $326.48 billion, a P/E ratio of 15.62, a P/E/G ratio of 2.34 and a beta of 0.47. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm’s revenue was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were given a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group’s payout ratio is 38.30%.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on UNH. Baird R W downgraded UnitedHealth Group from a “hold” rating to a “strong sell” rating in a report on Thursday, July 31st. Royal Bank Of Canada decreased their target price on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. Jefferies Financial Group lifted their target price on UnitedHealth Group from $317.00 to $409.00 and gave the stock a “buy” rating in a report on Friday, October 17th. Mizuho lifted their target price on UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a report on Thursday, October 9th. Finally, Robert W. Baird reaffirmed an “underperform” rating and set a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Eighteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $385.13.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.